Table 2.
Clearly Defined Aim | Consecutive Patients | Prospective Data Collection | Adequate Endpoint | Blind Assessment | Adequate Length of Follow-Up | Loss to Follow-Up Rate <5% | Prospective Calculation of the Study Size | Control Equivalent to Cases | Control Contemporaneous to Cases | Baseline Equivalence of Groups | Adequate Statistical Analysis | Total Score | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Götz et al. (2016) | 2 | 0 | 2 | 0 | 0 | 2 | 2 | 0 | 2 | 2 | 2 | 2 | 16/24 |
Vandekerckhove et al. (2014) | 2 | 2 | 2 | 1 | 1 | 2 | 2 | 0 | 2 | 2 | 2 | 2 | 20/24 |
Bascuas et al. (2013) | 2 | 2 | 2 | 1 | 0 | 2 | 1 | 0 | 2 | 2 | 1 | 2 | 17/24 |
Fuchs et al. (1999) | 2 | 1 | 2 | 1 | 0 | 2 | 0 | 0 | 2 | 2 | 0 | 2 | 14/24 |
Lattanzio et al. (1998) | 2 | 1 | 2 | 1 | 1 | 2 | 0 | 0 | 1 | 2 | 2 | 2 | 16/24 |
Ishii et al. (1997) | 1 | 1 | 2 | 1 | 0 | 2 | 1 | 0 | 1 | 2 | 1 | 2 | 14/24 |
Cash et al. (1996) | 2 | 1 | 2 | 1 | 1 | 2 | 2 | 0 | 0 | 2 | 2 | 2 | 17/24 |
Simmons et al. (1996) | 2 | 2 | 2 | 1 | 0 | 2 | 1 | 0 | 0 | 2 | 2 | 2 | 16/24 |
Warren et al. (1993) | 1 | 1 | 2 | 1 | 0 | 2 | 1 | 0 | 1 | 2 | 1 | 2 | 14/24 |